Management of newly diagnosed acute myeloid leukemia (AML) in patients deemed unfit for intensive chemotherapy is undergoing rapid transformation toward highly individualized regimens. The combination ...
Key points New evidence has led to a change in the way that some patients with amyotrophic lateral sclerosis (ALS) are classified and treated. Based on the findings of a landmark trial,[1][1] the drug ...
SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its ...
The global next generation sequencing market is set to witness a growth rate of ~15% in the next 5 years. Rising demand for ...
Health-tech companies are designing models that identify patients at risk of developing cancer, and who might need more screening or preventive care.
In view of persistent fever and cough, and the new onset of an accentuated confluent maculopapular rash, the patient was ...
Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.
This is clearly good news, though there is no claim of a cure and if it can be turned into a treatment, that will surely be ...
An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” study, according to drugmaker uniQure, marking a major step toward a potential first genetic ...
That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...
You get older every day. But how old are your cells and organs, really?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback